Presentations & Publications
// May 14, 2026 | Presentation
American Society of Gene and Cell Therapy (ASGCT)
Iterative Engineering and Optimization Strategies for Maximizing LNP-mediated Gene Editing in the Liver
// May 14, 2026 | Presentation
American Society of Gene and Cell Therapy (ASGCT)
Next‑generation enzymes for targeted gene insertion
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Sequencing-based analytics offer potential for rapid sterility and adventitious agent testing
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Harnessing a diverse collection of CRISPR-associated RNA-guided nucleases and novel reverse transcriptases for precise gene editing
// May 14, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Engineering hepatocyte-targeted LNPs for RNA and DNA delivery to primary human T cells
// May 13, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Leveraging generative AI to design novel, functional deaminases for adenine base editing
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Comprehensive off-target assessment strategies for CRISPR-based genome editing therapeutics: integrating biochemical, bioinformatic, and unbiased approaches
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Active learning-guided optimization of large gene insertion effectors in mammalian cells
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Versatile and robust epigenetic modulation platform for programmable gene activation and repression
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Leveraging protein and gRNA engineering of diverse CRISPR systems to optimize adenosine base editor activity for correction of a causative monogenic disease mutation
// May 06, 2026 | Poster
International Society for Cell & Gene Therapy (ISCT)
A Novel Non-Viral Platform Combining a LEG Nuclease and mbDNA for High-Efficiency T-Cell Engineering
// Apr 30, 2026 | Presentation
2026 Outsourced Pharma
